Trial · NCT01259297
Adverse event totals30
The totals the trial posted for each group.
1 to 20 of 30
Download this page as JSON| Total | Group | Affected | At risk |
|---|---|---|---|
| Total, all-cause mortality | Run-in Period: Aliskiren + Hydrochlorothiazide (HCTZ) | ||
| Total, all-cause mortality | Run-in Period: Aliskiren + Amlodipine | ||
| Total, all-cause mortality | Double Blind Period: Aliskiren + Hydrochlorothiazide (HCTZ) | ||
| Total, all-cause mortality | Double Blind Period: Aliskiren + Placebo for HCTZ | ||
| Total, all-cause mortality | Double Blind Period: Aliskiren + Amlodipine | ||
| Total, all-cause mortality | Double Blind Period: Aliskiren + Placebo for Amlodipine | ||
| Total, all-cause mortality | Double Blind Period: HCTZ + Placebo for Aliskiren | ||
| Total, all-cause mortality | Double Blind Period: Placebo for Aliskiren + Placebo for HCTZ | ||
| Total, all-cause mortality | Double Blind Period: Amlodipine + Placebo for Aliskiren | ||
| Total, all-cause mortality | Double Blind Period: Placebo for Aliskiren + Placebo for Amlod | ||
| Total, other adverse events | Run-in Period: Aliskiren + Hydrochlorothiazide (HCTZ) | 7 | 1,335 |
| Total, other adverse events | Run-in Period: Aliskiren + Amlodipine | 19 | 1,001 |
| Total, other adverse events | Double Blind Period: Aliskiren + Hydrochlorothiazide (HCTZ) | 6 | 244 |
| Total, other adverse events | Double Blind Period: Aliskiren + Placebo for HCTZ | 5 | 232 |
| Total, other adverse events | Double Blind Period: Aliskiren + Amlodipine | 9 | 189 |
| Total, other adverse events | Double Blind Period: Aliskiren + Placebo for Amlodipine | 8 | 195 |
| Total, other adverse events | Double Blind Period: HCTZ + Placebo for Aliskiren | 6 | 251 |
| Total, other adverse events | Double Blind Period: Placebo for Aliskiren + Placebo for HCTZ | 5 | 253 |
| Total, other adverse events | Double Blind Period: Amlodipine + Placebo for Aliskiren | 14 | 196 |
| Total, other adverse events | Double Blind Period: Placebo for Aliskiren + Placebo for Amlod | 3 | 199 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01259297/event-totals